Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 9;10(1):560.
doi: 10.1186/s13071-017-2503-z.

Production and characterization of monoclonal antibodies against Encephalitozoon intestinalis and Encephalitozoon sp. spores and their developmental stages

Affiliations

Production and characterization of monoclonal antibodies against Encephalitozoon intestinalis and Encephalitozoon sp. spores and their developmental stages

Fernando Izquierdo et al. Parasit Vectors. .

Abstract

Background: Microsporidia are intracellular obligate parasites traditionally associated with immunosuppressed patients; their detection in immunocompetent patients has increased, highlighting their possible importance as emerging pathogens. Detection of spores in stools, urine, body fluids and tissues is difficult and immunological techniques such as immunofluorescence have proved to be a useful and reliable tool in the diagnosis of human microsporidiosis. For this reason, we have produced and characterized monoclonal antibodies (MAbs) specific for Encephalitozoon intestinalis (the second most frequent microsporidian infecting humans), and other Encephalitozoon species, that can be used in different diagnostic techniques.

Results: Seven MAbs were selected in accordance with their optical density (OD). Four (4C4, 2C2, 2E5 and 2H2) were isotype IgG2a; two (3A5 and 3C9) isotype IgG3, and one Mab, 1D7, IgM isotype. The selected monoclonal antibody-secreting hybridomas were characterized by indirect immunofluorescence antibody test (IFAT), enzyme-linked immunosorbent assay (ELISA), Western blot, immunoelectron microscopy (Immunogold) and in vitro cultures. The study by IFAT showed different behavior depending on the MAbs studied. The MAbs 4C4, 2C2, 2E5 and 2H2 showed reactivity against epitopes in the wall of the spore (exospore and endospore) epitopes located in Encephalitozoon sp. spores, whereas the MAbs 3A5, 1D7 and 3C9 showed reactivity against internal epitopes (cytoplasmic contents or sporoplasm) of E. intestinalis spores. All MAbs recognized the developing parasites in the in vitro cultures of E. intestinalis. Additionally, 59 formalin-fixed stool samples that had been previously analyzed were screened, with 26 (44%) presenting microsporidian spores (18 samples with E. intestinalis and 8 samples with Enterocytozoon bieneusi). Detection of microsporidian spores by microscopy was performed using Calcofluor stain, Modified Trichrome, Quick-Hot Gram Chromotrope, as well as IFAT using MAbs 4C4, 2C2, 2E5 and 2H2. The 4 MAbs tested clearly recognized the larger spores corresponding to E. intestinalis, but showed no reactivity with Enterocytozoon bieneusi spores. The mass spectrometry and proteomic study revealed that the Mabs 4C4, 2C2, 2E5 and 2H2 recognized the Spore Wall Protein 1 (SWP1) as the antigenic target.

Conclusions: The IFAT-positive MAbs exhibited excellent reactivity against spores and developmental stages, permitting their use in human and animal diagnosis. The epitopes recognized (exospore, endospore and cytoplasmic contents) by the different MAbs developed need further study, and may reveal potential targets for vaccine development, immunotherapy and chemotherapy.

Keywords: Developmental stages; Diagnosis; Encephalitozoon intestinalis; Encephalitozoon sp.; Monoclonal antibodies; Spores.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Human fecal samples: all fecal samples were from patients in Atlanta hospitals and established in the CDC fecal bank at the Division of Parasitic Diseases (“Measure the incidence of and risk factors of diarrhea associated with parasitic infections among people infected with HIV” from January 1, 1991 to September 30, 1994/CDC). Informed consent was obtained from patients, and the guidelines for human experimentation of the U.S. Department of Health and Human Services (HHS) were followed. All samples were analyzed anonymously. The authors confirm that the study was reviewed and approved by an institutional review board (HHS) following the Basic HHS Policy for Protection of Human Research Subjects before the study began. Animals: all of the experimental procedures were carried out in accordance with Spanish legislation (Real Decreto 223/1988) and European Union (Council Directive 86/609/EEC) on the use of experimental animals, use of infectious agents and laboratory safety (Real Decreto 664/1997). The studies and protocols were approved by the Veterinary Commission of the University San Pablo CEU (references no. 09/98 and 01/99).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Western blot of SDS-PAGE (12%) separated proteins of E. intestinalis. Undiluted monoclonal antibodies: Pattern 1 (MAbs 4C4, 2C2 and 2H2); Pattern 2 (MAb 2E5); Pattern 3 (MAbs 3C9 and 1D7); Pattern 4 (MAb 3A5)
Fig. 2
Fig. 2
Immunogold electron micrographs of Encephalitozoon intestinalis spores after incubation with MAbs. Undiluted supernatant were used: 2C2 (a), 3C9 (b), 2E5 (c) and 4C4 (d). Scale-bars: a, 0.3 μm; b, 0.25 μm; c, 0.5 μm; d, 0.2 μm
Fig. 3
Fig. 3
Immunorecognized in culture cell (Vero-E6) of E. intestinalis after incubation with MAb 2E5 (undiluted supernatant). a 24 hpi. b 72 hpi. Abbreviations: N, nucleus; Pv, parasitophorous vacuole; Sd, stages of development; hpi, hours post-infection
Fig. 4
Fig. 4
Formalin-fixed fecal samples from patients with microsporidia. a Fecal smear stained by the Modified Trichrome technique. b Encephalitozoon intestinalis spores detected by IFAT with the MAb 2E5. c and d are the same field: c Fecal smear stained by the Calcofluor technique. d Spores detected by IFAT with MAb 2C2. Scale-bars: 4 μm
Fig. 5
Fig. 5
Soluble antigen profiles of E. cuniculi. a Soluble antigen in NuPage® gel stained with Coomasie Blue. b Immunoreactivity profile of MAb 2C2 (dilution 1:20, iBlot™ Dry Blotting System, Invitrogen™)

Similar articles

Cited by

References

    1. Didier ES, Didier PJ, Snowden KF, Shadduck JA. Microsporidiosis in mammals. Microbes Infect. 2000;2:709–720. doi: 10.1016/S1286-4579(00)00354-3. - DOI - PubMed
    1. Didier ES. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop. 2005;94:61–76. doi: 10.1016/j.actatropica.2005.01.010. - DOI - PubMed
    1. Ojuromi OT, Izquierdo F, Fenoy S, Fagbenro-Beyioku A, Oyibo W, Akanmu A, et al. Identification and characterization of microsporidia from fecal samples of HIV-positive patients from Lagos, Nigeria. PLoS One. 2012;7:e35239. doi: 10.1371/journal.pone.0035239. - DOI - PMC - PubMed
    1. Sak B, Kváč M, Kučerová Z, Květoňová D, Saková K. Latent microsporidial infection in immunocompetent individuals - a longitudinal study. PLoS Negl Trop Dis. 2011;5:e1162. doi: 10.1371/journal.pntd.0001162. - DOI - PMC - PubMed
    1. Weber R, Bryan RT, Schwartz DA, Owen RL. Human microsporidial infections. Clin Microbiol Rev. 1994;7:426–461. doi: 10.1128/CMR.7.4.426. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources